Rising inflammatory factors such as IL-17A may promote an increase in intracellular cholesterol and then inflow circulation, leading to a parallel rise in blood cholesterol levels, which may be one of the reasons for psoriasis and dyslipidemia comorbidity (Varshney et al., 2016). Here, IL17A is linked to psoriasis.